Reputation – MPs: Research and development
Read more about how members of parliament see the pharmaceutical sector’s contribution to research and development
The recognition of R&D investment underpins perceptions of pharmaceutical companies operating in the UK as ‘innovative’ and a key factor that promotes advocacy among over one in three MPs.
They also see innovation and R&D investment as bringing social and economic benefits to the UK through job creation, skill development and educational investment via academic partnerships.
57% of MPs think that pharmaceutical companies invest the most in R&D in the UK in an average year compared with other sectors
Please indicate how strongly you agree or disagree with the following statements:
Pharmaceutical companies operating in the UK… (% Strongly agree/tend to agree)
Because [Pharmaceutical companies operating in the UK] are an important part of the UK economy, it’s an important area of innovation and entrepreneurialism in which the UK is held in high regard and it is a large employer and responsible for a large amount of inward investment. Conservative Backbencher
Which two or three words or phrases would you use to describe pharmaceutical companies operating in the UK?
MPs agree that pharmaceutical companies operating in the UK produce effective medicines
MPs’ perception of an ‘innovative’ pharmaceutical sector is paired with a recognition of its competence. Most MPs think that pharmaceutical companies operating in the UK produce effective medicines. However, fewer are certain that the side effects of medicines are communicated clearly or that the sector is transparent about clinical trial results.
Please indicate how strongly you agree or disagree with the following statements:
Pharmaceutical companies operating in the UK…(% Strongly agree/tend to agree)
Please indicate how strongly you agree or disagree with the following statements:
Pharmaceutical companies operating in the UK…
Last modified: 20 September 2023
Last reviewed: 20 September 2023